Failure to conform to claim. Clinical performance does not meet the supporting clinical study data for percentage recovery. Poor separation, resulting in a reduced number of recovered mononuclear cells. Having an insufficient number of isolated mononuclear cells may lead to possible specimen recollection, potential delay in treatment, and in remote cases, it could lead to erroneous results. No adverse events have been reported for this issue.